Human allogeneic mesenchymal bone marrow cell therapy (Medstar Health Research Institute)

N/A

Report date: 2022/11/20 22:31:20

Base Information

Drug NameHuman allogeneic mesenchymal bone marrow cell therapy (Medstar Health Research Institute)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsMyocardial IschemiaCardiomyopathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedstar Health Research Institute Inc

China Registration ClassN/A

Develop Information

Active CompaniesMedstar Health Research Institute Inc

Inactive CompaniesN/A

Active IndicationsMyocardial Ischemia

Inactive IndicationsCardiomyopathies

Other Information

ATC CodeN/A